Related Experiment Video
Updated: Aug 4, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care
Guneive Mangat1, Nikhil Nair2, Oren Barat3
1Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
Insights
Obesity-related glomerulopathy (ORG) is a kidney disease linked to obesity, primarily caused by podocyte damage. Key treatments involve weight loss and reducing proteinuria through lifestyle changes, medication, or surgery.
Area of Science:
- Nephrology
- Endocrinology
- Public Health
Background:
- Obesity is a global pandemic linked to numerous comorbidities.
- Obesity-related glomerulopathy (ORG) is an emerging kidney disease associated with obesity.
- ORG is characterized by podocyte damage, with contributing factors including RAAS activation, hyperinsulinemia, and lipid deposition.
Purpose of the Study:
- To review the pathogenesis, clinical features, and treatment of obesity-related glomerulopathy (ORG).
- To highlight the importance of addressing childhood obesity for primary prevention of ORG.
- To discuss established and novel therapeutic strategies for ORG.
Main Methods:
- Literature review of obesity-related glomerulopathy (ORG).
- Analysis of current understanding of ORG pathophysiology.
- Examination of treatment modalities for ORG.
Main Results:
- Podocyte damage is the primary cause of ORG.
- Weight loss and proteinuria reduction are crucial for managing ORG.
- Lifestyle modification, pharmacotherapy, and surgery are primary treatment approaches.
Conclusions:
- Understanding ORG pathophysiology is advancing.
- Effective management of ORG requires a multi-faceted approach.
- Preventing childhood obesity is essential for long-term ORG reduction.
Abstract:
Obesity has continued to emerge as a worldwide pandemic and has been associated with a significant increase in associated comorbidities. These include well-known conditions such as hypertension and diabetes, as well as lesser-known conditions such as obesity-related glomerulopathy (ORG). The main etiology of ORG is podocyte damage, but contributing theories include dysfunctional renin-angiotensin-aldosterone system activation, hyperinsulinemia and lipid deposition. Recent advances have made strides in understanding the complex pathophysiology of ORG. The key to treating ORG is weight loss and proteinuria reduction. Lifestyle modification, pharmacological interventions and surgery are mainstays of management. A special focus on obese children is required, as childhood obesity tracks into adulthood and primary prevention is key. In this review we discuss the pathogenesis, clinical features and established and newer treatment modalities of ORG.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations